albumin

  • Master file for recombinant albumin

    Novozymes Biopharma announces that the US FDA Center for Biologics Evaluation and Research (FDA / CBER) has accepted a Type IV Master File for its recombinant albumin, albucult. The dossier which contains proprietary information on the manufacture a…

    albumin | 30 September 2010

  • Novozymes and Prometic Team Up For Purification Of Proteins

    Novozymes and ProMetic Life Sciences have entered into a strategic alliance regarding proprietary albumin purification technology that is based upon a synthetic-ligand affinity adsorbent developed by the latter’s UK subsidiary, ProMetic BioSciences…

    albumin | 04 February 2010